S. 5571 (119th)Passage Likelihood
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
domestic policy
Sponsor
Cosponsors
Support
Lean Republican
Introduced
Sep 28, 2026
Discussions
Current stageCommittee
Read twice and referred to the Committee on Finance.
Introduced
Committee
Floor
President
Law
Loading passage likelihood analysis...